ChristianaCare

Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, ChristianaCare is implementing a temporary visitation age restriction starting Tuesday, Jan. 21. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.


Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, ChristianaCare está implementando una restricción temporal en la edad de visitantes a partir del viernes 21 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Cancer Research

 

At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute

Dr. Bruce Boman conducts cancer research at ChristianaCare Dr. Pradhan-Bhatt leads cancer research at ChristianaCare Dr. Eric Kmiec conducts gene editing cancer research at ChristianaCare Dr. Mourtada conducts radiation oncology cancer research at ChristianaCare Dr. Sims-Mourtada irradiates a cancer research specimen at ChristianaCare

At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, ground-breaking cancer research is every-day reality. The Graham Cancer Center brings scientists and clinicians together to investigate innovative ways to diagnose cancer earlier and treat it more effectively.

Because of its membership in the prestigious National Cancer Institute NCI Community Oncology Research Program (NCORP), the Graham Cancer Center offers leading-edge NCORP clinical trials to the patients we are privileged to serve. The Graham Cancer Center also offers a robust pharmaceutical clinical trials program.

In addition to clinical trials, the Graham Cancer Center has a translational cancer research program at the Center for Translational Cancer Research (CTCR) that brings scientific discoveries from the bench to the bedside of patients, investigating breast cancer, colon cancer, radiation oncology and tissue engineering. The Graham Cancer Center conducts industry-leading genetic engineering cancer research at the Gene Editing Institute.

The Graham Cancer Center collaborates with other institutions in cancer research, having close partnerships with The Wistar Institute, the University of Delaware, Nemours / A.I. du Pont Hospital for Children, Rice University / BioScience Research Collaborative and the Delaware Biotechnology Institute, among others.